NCT00399867View on ClinicalTrials.gov

Simvastatin as Inhibitor of Cell Adhesion Mediated Drug Resistance in Patients With Refractory Multiple Myeloma.

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

April 30, 2007

Conditions
Multiple Myeloma
Interventions
DRUG

Simvastatin

All Listed Sponsors
lead

Ludwig-Maximilians - University of Munich

OTHER

NCT00399867 - Simvastatin as Inhibitor of Cell Adhesion Mediated Drug Resistance in Patients With Refractory Multiple Myeloma. | Biotech Hunter | Biotech Hunter